Evogene Ltd.
EVGN.TA
Get informed when a big investor buys or sells
+ FollowMarket Cap$10.56M
Close$
Share Statistics
| Market cap | $10.56 Million |
|---|---|
| Enterprise Value | $3.34 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.08 |
| Beta | 0.68 |
| Outstanding Shares | 12,199,883 |
Return
| Return on Equity | 335.26% |
|---|---|
| Return on Assets | -82.07% |
| Return on Invested Capital | -203.83% |
Valuation & Multiples
| P/E Ratio | -0.44 |
|---|---|
| PEG | 0.72 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 0.69 |
| Enterprise Value to EBIT | -0.16 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.64 |
| Debt to Equity | -0.64 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 18, 2026
EPS Estimate
$-0.80
Average shareholder expectationRevenue Estimate
$967,406
Average shareholder expectationNext Earnings Call
Expected Date
November 18, 2026
EPS Estimate
$-0.58
Average shareholder expectationRevenue Estimate
$1.12 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Evogene Ltd
52 employees
CEO: Ofer Haviv Evogene Ltd. engages in the development and commercialization of a computer-biological platform for improving the development processes of products in the field of life sciences. It operates through the following segments: Agriculture, I...